Suven Pharmaceuticals Limited Share Price Bombay S.E.
Equities
SUVENPHAR
INE03QK01018
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
644.4 INR | -2.04% | +0.33% | -11.25% |
03-27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
03-05 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
Sales 2023 | 13.4B 161M 12.8B | Sales 2024 * | 10.9B 131M 10.41B | Capitalization | 166B 1.99B 158B |
---|---|---|---|---|---|
Net income 2023 | 4.11B 49.31M 3.93B | Net income 2024 * | 3.34B 40.07M 3.19B | EV / Sales 2023 | 8.97 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 15.2 x |
P/E ratio 2023 |
29.2
x | P/E ratio 2024 * |
49.5
x | Employees | 1,193 |
Yield 2023 * |
0.36% | Yield 2024 * |
0.27% | Free-Float | 37.48% |
Latest transcript on Suven Pharmaceuticals Limited
1 day | -2.04% | ||
1 week | +0.33% | ||
Current month | -4.75% | ||
1 month | -4.75% | ||
3 months | -5.57% | ||
6 months | +13.71% | ||
Current year | -11.25% |
Managers | Title | Age | Since |
---|---|---|---|
Sudhir Singh
CEO | Chief Executive Officer | - | 28/09/23 |
Himanshu Agarwal
DFI | Director of Finance/CFO | 30 | 12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 28/09/23 | |
Shweta Jalan
BRD | Director/Board Member | 48 | 11-08 |
Director/Board Member | 62 | 11-08 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 644.4 | -2.04% | 7 479 |
26/04/24 | 657.9 | +2.02% | 3,939 |
25/04/24 | 644.8 | +1.27% | 5,898 |
24/04/24 | 636.8 | -1.10% | 1,651 |
23/04/24 | 643.8 | +0.98% | 5,883 |
Delayed Quote Bombay S.E., April 29, 2024 at 11:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.55% | 661B | |
+26.74% | 566B | |
-6.60% | 352B | |
+19.51% | 332B | |
+3.64% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.12% | 145B |
- Stock Market
- Equities
- SUVENPHAR Stock
- SUVENPHAR Stock